Canada markets closed
  • S&P/TSX

    21,125.90
    -487.28 (-2.25%)
     
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • DOW

    34,899.34
    -905.04 (-2.53%)
     
  • CAD/USD

    0.7816
    -0.0089 (-1.12%)
     
  • CRUDE OIL

    68.15
    -10.24 (-13.06%)
     
  • BTC-CAD

    69,580.35
    -1,371.25 (-1.93%)
     
  • CMC Crypto 200

    1,365.60
    -89.82 (-6.17%)
     
  • GOLD FUTURES

    1,788.10
    +1.20 (+0.07%)
     
  • RUSSELL 2000

    2,245.94
    -85.52 (-3.67%)
     
  • 10-Yr Bond

    1.4820
    -0.1630 (-9.91%)
     
  • NASDAQ

    15,491.66
    -353.57 (-2.23%)
     
  • VOLATILITY

    28.62
    +10.04 (+54.04%)
     
  • FTSE

    7,044.03
    -266.34 (-3.64%)
     
  • NIKKEI 225

    28,751.62
    -747.66 (-2.53%)
     
  • CAD/EUR

    0.6901
    -0.0147 (-2.09%)
     

Global qPCR Instruments Market (2021 to 2028) - Size, Share & Trends Analysis Report

·10 min read

Dublin, Oct. 19, 2021 (GLOBE NEWSWIRE) -- The "qPCR Instruments Market Size, Share & Trends Analysis Report By Instrument (GeneXpert, BioFireFilmArray Systems, BMS Mic System), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global qPCR instruments market size is expected to reach USD 1.39 billion by 2028, according to a new report by the publisher It is expected to expand at a CAGR of 3.4% from 2021 to 2028. The market is driven by the introduction of novel advanced products and an increase in demand for highly efficient diagnostic equipment.

The demand for qPCR instruments and consumables is being driven by the spike in the incidence of SARS-CoV-2 infections globally. The rise in the incidence is expected to add to the number of preventive screenings. This can be attributed to the fact that nations cannot determine the number of COVID-19 patients without screening them.

The miniaturization of three basic molecular assays is expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to improve the availability of POC molecular diagnostic tests to yield quick and effective test results. For instance, the Mic qPCR system by Biomolecular Systems weighs only 2 kilograms, making the device highly portable and easy to handle.

Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages. Furthermore, the approval of the instrument in over 50 countries can help strengthen the market growth. The instrument is also equipped with measures for research companion diagnostics, giving it a competitive edge.

The market has a high threat of external substitutes owing to the presence of digital PCR instruments that are highly advanced and more accurate. The strong threat of internal substitution can be attributed to the presence of numerous products available in the market. However, the higher price of these instruments is anticipated to reduce the overall threat, keeping it at a moderate level.

COVID-19 has increased opportunities for diagnostic devices. However, advanced PCR technologies, such as dPCR, are preferred more in developed economies as they can help reduce false-positive rates. The research on developing efficient qPCR instruments can reduce the threat of substitution of devices and improve market growth.

Over recent years, PCR has witnessed technological advancements in terms of sensitivity, accuracy, efficiency, and cost-effectiveness. Key players are introducing novel technologies to maintain a competitive edge.

qPCR Instruments Market Report Highlights

  • By instrument, the GeneXpert segment is expected to exhibit the fastest CAGR from 2021 to 2028

  • Asia Pacific is expected to witness the fastest growth over the forecast period due to the increasing number of investments aimed at improving diagnostic infrastructure and the growing prevalence of infectious diseases

  • Unmet needs in the market are high. For instance, the lack of affordable qPCR instruments is keeping the market from reaching its full potential

  • Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages

  • North America captured the largest revenue share in 2020 and is expected to maintain its lead over the forecast period. Improving regulatory support and increasing launches of novel products are anticipated to fuel the market growth

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 qPCR Instruments Market Variables, Trends & Scope
3.1 qPCR Instruments Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Regulatory and Reimbursement Framework
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
3.3.1.2 Technological advancements in PCR
3.3.1.3 Implementation of MIQE guidelines
3.3.1.4 Increasing adoption of qPCR technologies
3.3.1.5 Increase in number of CROs and forensic & research laboratories
3.3.1.6 Increasing demand for prenatal genetic testing procedures
3.3.1.7 Increase in demand for point-of-care diagnostics
3.3.2 Market restraint analysis
3.3.2.1 Presence of stringent regulatory framework
3.3.2.2 High prices of qPCR Instruments
3.4 Porter's Five Forces Analysis
3.5 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 New product launch
3.6.2 Mergers and acquisitions
3.6.3 Expansion
3.6.4 Partnerships
3.7 Opportunity Analysis for qPCR
3.7.1 Unmet needs
3.7.2 Change in market dynamics after the launch of new products
3.7.3 Consumer behavior analysis

Chapter 4 qPCR Instruments Market: Segment Analysis, by Instrument, 2017 - 2028 (USD Million)
4.1 Global qPCR Instrument Market, by Instrument, 2017 to 2028
4.2 Definition and Scope
4.3 Market Size & Forecasts and Trend Analyses, 2017 to 2028
4.3.1 Thermo Fisher Scientific, Inc.
4.3.1.1 7500
4.3.1.1.1 7500
4.3.1.1.2 7500 Fast
4.3.1.1.3 7500 Fast Dx
4.3.1.1.4 7500 Market, 2017 - 2028 (USD Million)
4.3.1.2 QuantStudio Dx Real-Time PCR
4.3.1.2.1 Quantstudio Dx Market, 2017 - 2028 (USD Million)
4.3.1.3 QuantStudio 5 Dx Real-Time PCR
4.3.1.3.1 Quantstudio 5 DX Market, 2017 - 2028 (USD Million)
4.3.1.4 ViiA 7 Dx
4.3.1.4.1 Vii A Dx Market, 2017 - 2028 (USD Million)
4.3.1.5 StepOne / StepOne Plus Real-Time PCR Systems
4.3.1.5.1 StepOne /StepOne Plus system Market, 2017 - 2028 (USD Million)
4.3.2 F. Hoffmann-La Roche Ltd.
4.3.2.1 LightCycler 2.0/ 96/ 480/ 1536
4.3.2.1.1 LightCycler 2.0/ 96/ 480/ 1536 Market, 2017 - 2028 (USD Million)
4.3.2.2 Cobas 4800
4.3.2.2.1 Cobas 4800 Market, 2017 - 2028 (USD Million)
4.3.3 Bio-Rad Laboratories, Inc.
4.3.3.1 CFX96
4.3.3.1.1 CFX 96 Market, 2017 - 2028 (USD Million)
4.3.4 Danaher Corporation
4.3.4.1 SmartCycler
4.3.4.1.1 SmartCycler Market, 2017 - 2028 (USD Million)
4.3.4.2 GeneXpert
4.3.4.2.1 GeneXpert Market, 2017 - 2028 (USD Million)
4.3.5 QIAGEN
4.3.5.1 Rotor-Gene Q
4.3.5.1.1 Rotor Gene Q Market, 2017 - 2028 (USD Million)
4.3.5.2 Rotor-Gene Q MDx 5plex HRM
4.3.5.2.1 Rotor Gene Q MDx 5plex HRM Market, 2017 - 2028 (USD Million)
4.3.6 bioMerieux SA
4.3.6.1 BioFire FlimArray Systems
4.3.6.1.1 BioFire FilmArray Systems Market, 2017 - 2028 (USD Million)
4.3.7 Bio Molecular Systems
4.3.7.1 BMS Mic System
4.3.7.1.1 BMS Mic qPCr system Market, 2017 - 2028 (USD Million)

Chapter 5 qPCR Instruments Market: Regional Market Analysis, 2017 - 2028 (USD Million)
5.1 Definition & Scope
5.2 Regional Market Share Analysis, 2020 & 2028
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot
5.5 Market Size, & Forecasts, Trend Analysis, 2020 to 2028
5.6 North America
5.6.1 North America qpcr Market estimates and forecast, 2017 - 2028 (USD Million)
5.6.2 U.S.
5.6.2.1 U.S. qPCR Instruments Market, 2017 - 2028 (USD Million)
5.6.3 Canada
5.6.3.1 Canada qPCR Instruments Market, 2017 - 2028 (USD Million)
5.7 Europe
5.7.1 Europe qPCR Instruments Market, 2017 - 2028 (USD Million)
5.7.2 U.K.
5.7.2.1 U.K. qPCR Instruments Market, 2017 - 2028 (USD Million)
5.7.3 Germany
5.7.3.1 Germany qPCR Instruments Market, 2017 - 2028 (USD Million)
5.7.4 Spain
5.7.4.1 Spain qPCR Instruments Market, 2017 - 2028 (USD Million)
5.7.5 France
5.7.5.1 France qPCR Instruments Market, 2017 - 2028 (USD Million)
5.7.6 Italy
5.7.6.1 Italy qPCR Instruments Market, 2017 - 2028 (USD Million)
5.8 Asia Pacific
5.8.1 AsiaPacific qPCR Instruments Market, 2017 - 2028 (USD Million)
5.8.2 Japan
5.8.2.1 Japan qPCR Instruments Market, 2017 - 2028 (USD Million)
5.8.3 China
5.8.3.1 China qPCR Instruments Market, 2017 - 2028 (USD Million)
5.8.4 India
5.8.4.1 India qPCR Instruments Market, 2017 - 2028 (USD Million)
5.9 Latin America
5.9.1 Latin America qPCR Instruments Market, 2017 - 2028 (USD Million)
5.9.2 Brazil
5.9.2.1 Brazil qPCR Instruments Market, 2017 - 2028 (USD Million)
5.9.3 Mexico
5.9.3.1 Mexico qPCR Instruments Market, 2017 - 2028 (USD Million)
5.10 MEA
5.10.1 MEA qPCR Instruments Market, 2017 - 2028 (USD Million)
5.10.2 South Africa
5.10.2.1 South Africa qPCR Instruments Market, 2017 - 2028 (USD Million)
5.10.3 UAE
5.10.3.1 UAE qPCR Instruments Market, 2017 - 2028 (USD Million)

Chapter 6 Competitive Landscape
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.1.1 Ansoff matrix
6.2 Company Categorization
6.2.1 Innovators
6.3 Vendor Landscape
6.3.1 List of key distributors and channel partners
6.3.2 Key customers
6.4 Public Companies
6.4.1 Company market position analysis
6.4.2 Competitive Dashboard Analysis
6.4.2.1 Market Differentiators
6.5 Private Companies
6.5.1 List of key emerging companies
6.6 Company Profiles
6.6.1 Thermo Fisher Scientific, inc.
6.6.1.1 Company Overview
6.6.1.2 Financial Performance
6.6.1.3 Product Benchmarking
6.6.1.4 Strategic Initiatives
6.6.2 F. Hoffmann-La Roche Ltd.
6.6.2.1 Company Overview
6.6.2.2 Financial Performance
6.6.2.3 Product Benchmarking
6.6.2.4 Strategic Initiatives
6.6.3 Bio-Rad Laboratories, Inc.
6.6.3.1 Company Overview
6.6.3.2 Financial Performance
6.6.3.3 Product Benchmarking
6.6.3.4 Strategic Initiatives
6.6.4 Danaher Corporation
6.6.4.1 Company Overview
6.6.4.2 Cepheid
6.6.4.3 Beckman Coulter
6.6.4.4 Financial Performance
6.6.4.5 Product Benchmarking
6.6.5 Qiagen
6.6.5.1 Company Overview
6.6.5.2 Financial Performance
6.6.5.3 Product Benchmarking
6.6.5.4 Strategic Initiatives
6.6.6 Agilent Technologies, Inc.
6.6.6.1 Company Overview
6.6.6.2 Financial Performance
6.6.6.3 Product Benchmarking
6.6.6.4 Strategic Initiatives
6.6.7 Abbott
6.6.7.1 Company Overview
6.6.7.2 Alere, Inc.
6.6.7.3 Financial Performance
6.6.7.4 Product Benchmarking
6.6.7.5 Strategic Initiatives
6.6.8 bioMerieux SA
6.6.8.1 Company Overview
6.6.8.2 Financial Performance
6.6.8.3 Product Benchmarking
6.6.8.4 Strategic Initiatives
6.6.9 Quantabio
6.6.9.1 Company Overview
6.6.9.2 Product Benchmarking
6.6.9.3 Strategic Initiatives
6.6.10 Azure Biosystems, Inc.
6.6.10.1 Company Overview
6.6.10.2 Product Benchmarking
6.6.10.3 Strategic Initiatives
6.6.11 Bio Molecular Systems
6.6.11.1 Company Overview
6.6.11.2 Product Benchmarking
6.6.11.3 Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/do235e

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting